The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment ...

The clinic says in some cases, myocarditis can lead to serious complications. It goes on to say that myocarditis is also ...

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...

The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

Business interests and intellectual property laws privilege the wealthy and leave the rest scrabbling for life-saving ...

By Tom Crann and Gretchen Brown, Minnesota Public Radio News With federal vaccine funding up in the air, a University of ...

Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...

Elsewhere, Slovak Academy of Sciences tasked with looking into safety of COVID mRNA vaccines; four Czech soldiers indicted ...

Measles, once virtually wiped out in the United States, could become commonplace again if declining vaccination rates ...